NCT05238831 2024-01-23SMMART Adaptive Clinical Treatment (ACT) TrialOHSU Knight Cancer InstitutePhase EARLY_PHASE1 Withdrawn
NCT01086345 2018-07-03Radiosurgery Plus Bevacizumab in GlioblastomaCase Comprehensive Cancer CenterPhase EARLY_PHASE1 Terminated9 enrolled